跳至主要内容
临床试验/CTRI/2022/02/040601
CTRI/2022/02/040601已完成未知

Clinical assessment of anti sickling herbo- mineral formulation T-AYU-HM Premium on sickle cell anemia at Dhanvantari Clinic OPD patients: A Retrospective Study

Dhanvantari Clinic Ayurveda Health Care Research Center0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Patients were treated with T-AYU-HM Premium for sickle cell anemia at Dhanvantari Clinic between 1st January 2018 to 31st December 2020.
  • 2.Patients with a diagnosis of Sickle Cell Anemia (SCT/SCD)
  • 3.Patients = 5 years of age
  • 4. Patient’s = 3 months of follow-up data available from the first treatment at the center.
  • 5. Patient’s visited OPD of clinic regularly on scheduled appointment date
  • 6. Patients who were hospitalized for crisis condition.

排除标准

  • 1.Patients who were taking other medicines for anemia
  • 2. Pregnant and lactating women.
  • 3. Patient’s laboratory parameters data are not available.
  • 4. Patients follow-up is irregular

研究者

发起方
Dhanvantari Clinic Ayurveda Health Care Research Center

相似试验